Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Antoine

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2008
Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the scienceDaniel J Antoine, Dominic P Williams, B Kevin Park
BMJ (Clinical Research Ed.)|July 12, 2015
Where are we now with paracetamol?James W Dear, Daniel J Antoine, B Kevin Park
Expert Opinion on Drug Safety|March 1, 2016
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Joanna I Clarke, James W Dear, Daniel J Antoine
Journal of Leukocyte Biology|March 1, 2013
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxisHuan Yang, Daniel J Antoine, Ulf Andersson, et al.
Biochemical Pharmacology|September 29, 2009
Statins inhibit aminoglycoside accumulation and cytotoxicity to renal proximal tubule cellsDaniel J Antoine, Abhishek Srivastava, Munir Pirmohamed, et al.
British Journal of Clinical Pharmacology|June 16, 2015
Target biomarker profile for the clinical management of paracetamol overdoseA D Bastiaan Vliegenthart, Daniel J Antoine, James W Dear
Pediatric Nephrology (Berlin, Germany)|November 17, 2016
Aminoglycoside-induced nephrotoxicity in childrenStephen J McWilliam, Daniel J Antoine, Rosalind L Smyth, et al.
Antioxidants & Redox Signaling|October 21, 2015
Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic TargetsJonathan D Lea, Joanna I Clarke, Niamh McGuire, et al.
Hepatology (Baltimore, Md.)|August 5, 2014
Understanding the pathophysiological regulatory role of microRNAs in acute liver failureDaniel J Antoine, James W Dear, Christopher E Goldring, et al.
Biomarkers in Medicine|June 6, 2013
Are we closer to finding biomarkers for identifying acute drug-induced liver injury?Daniel J Antoine, Philip Starkey Lewis, Christopher E Goldring, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2008
Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the scienceDaniel J Antoine, Dominic P Williams, B Kevin Park
BMJ (Clinical Research Ed.)|July 12, 2015
Where are we now with paracetamol?James W Dear, Daniel J Antoine, B Kevin Park
Expert Opinion on Drug Safety|March 1, 2016
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Joanna I Clarke, James W Dear, Daniel J Antoine
Journal of Leukocyte Biology|March 1, 2013
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxisHuan Yang, Daniel J Antoine, Ulf Andersson, et al.
Biochemical Pharmacology|September 29, 2009
Statins inhibit aminoglycoside accumulation and cytotoxicity to renal proximal tubule cellsDaniel J Antoine, Abhishek Srivastava, Munir Pirmohamed, et al.
British Journal of Clinical Pharmacology|June 16, 2015
Target biomarker profile for the clinical management of paracetamol overdoseA D Bastiaan Vliegenthart, Daniel J Antoine, James W Dear
Pediatric Nephrology (Berlin, Germany)|November 17, 2016
Aminoglycoside-induced nephrotoxicity in childrenStephen J McWilliam, Daniel J Antoine, Rosalind L Smyth, et al.
Antioxidants & Redox Signaling|October 21, 2015
Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic TargetsJonathan D Lea, Joanna I Clarke, Niamh McGuire, et al.
Hepatology (Baltimore, Md.)|August 5, 2014
Understanding the pathophysiological regulatory role of microRNAs in acute liver failureDaniel J Antoine, James W Dear, Christopher E Goldring, et al.
Biomarkers in Medicine|June 6, 2013
Are we closer to finding biomarkers for identifying acute drug-induced liver injury?Daniel J Antoine, Philip Starkey Lewis, Christopher E Goldring, et al.
Pageof 11